Aquantia

Practice Area: 
Stock Symbol: 
AQ
Case Status: 
Investigations

Ademi & O’Reilly, LLP is investigating the Board of Aquantia, Corp. (NYSE: AQ) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of AQ to Marvell.

Ademi & O’Reilly, LLP alleges AQ’s financial outlook is improving and yet AQ shareholders will receive the only $13.25 per share.  Marvell is purchasing AQ at a substantial discount.  The merger agreement unreasonably limits competing bids for AQ by prohibiting solicitation of further bids, and imposing a termination penalty if AQ accepts a superior bid. AQ insiders will receive millions of dollars as part of change of control arrangements. We are investigating on the conduct of AQ’s board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for AQ.